SO
INDV icon

STRS Ohio’s Indivior Pharmaceuticals INDV Stock Holding History

STRS Ohio’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Sell
8,200
-29,400
-78% -$1.07M ﹤0.01% 1348
2026
Q1 		$1.15M Buy
37,600
+1,500
+4% +$49.5K ﹤0.01% 682
2025
Q4 		$1.3M Sell
36,100
-8,900
-20% -$272K ﹤0.01% 635
2025
Q3 		$1.08M Sell
45,000
-11,200
-20% -$234K ﹤0.01% 663
2025
Q2 		$828K Buy
+56,200
New +$655K ﹤0.01% 990

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

STRS Ohio's INDV Position: Q2 2026 in Review

STRS Ohio reduced its Indivior Pharmaceuticals (INDV) stake by 78% in Q2 2026, selling an estimated $1.07M and leaving 8,200 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #1348.

STRS Ohio first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.3M in Q4 2025. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • STRS Ohio held 8,200 shares of Indivior Pharmaceuticals worth $336K as of Q2 2026.
  • STRS Ohio sold 29,400 Indivior Pharmaceuticals shares in Q2 2026, an estimated $1.07M.
  • Indivior Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1348 holding.
  • STRS Ohio first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • STRS Ohio's Indivior Pharmaceuticals position peaked at $1.3M in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.